Cell Therapy Market by Cell Type (Stem Cell, Non-stem Cell), by Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, Other Therapies), by Therapy Type (Autologous, Allogeneic), by Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa): Opportunity Analysis and Industry Forecast 2021–2027

Date : Jul 2021

|

Report ID : 504

|

Category : Biotechnology

|
Report Format:  PDF EXCEL PPT WORD

Market Overview:

The Global Cell Therapy Market was valued at US$ 7.7 billion in 2020, and it is expected to reach US$ 19.5 billion by 2027, with a CAGR of 14.2%, during the forecast period, 2021 - 2027.

A therapy in which the human cells are used to repair or replace the damaged tissue. Through this way it helps to treat many disorders and resolves many health issues. The rising research activity and developments in the field of cell therapy enabled many different cells to use as a therapy for various diseases. The cells used in this therapy are such as dendritic cells, skeletal muscle stem cells, lymphocytes, mesenchymal stem cells, hematopoietic stem cells, and others. Evolving research activity has made it possible to develop novel cell therapies and are successfully utilized to treat various disorders across the globe. The key applications of cell therapy include cancer treatment, urinary issues, autoimmune disease, spinal cord related injuries, infectious disease treatment, immune system improvement, and in the treatment of several neurological disorders.

Cell Therapy Market

Rising health issues, growing obese and ageing population across the globe are some of the key factors driving growth of the global cell therapy market. The obesity is a leading cause of various chronic disease the owing to unhealthy diet habits the obesity is growing rapidly across the globe. This in turn driving demand for cell therapies specially in developed countries across the globe. Moreover, rising number of cancer infected individuals is also generating huge demand for the cell therapy and is expected to support growth of the global market over the forecast period.

The Global Cell Therapy Market Segmentation:

By Cell Type

  • Stem Cell
    • Bone Marrow
    • Blood
    • Umbilical Cord-Derived
    • Adipose-Derived Stem Cell
    • Others
  • Non-stem Cell

By Therapeutic Area

  • Malignancies
  • Musculoskeletal Disorders
  • Autoimmune Disorders
  • Dermatology
  • Other Therapies

By Therapy Type

  • Autologous
  • Allogeneic

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle-East and Africa

Based on cell type, stem cell is the most dominant category in the cell therapy industry and is expected to show a high growth during the forecast period

Based on cell type, the global cell therapy market can be segmented as stem cell, bone marrow, blood, umbilical cord-derived, adipose-derived stem cell, others, and non-stem cell. Among these, stem cell therapy holds the largest share in the cell therapy industry and is expected to show a high growth during the forecast period. Increasing funding for research activities stem cell field is driving growth of the stem cell segment growth.

There has been an increase in the demand for cancer treatment which is another major factor supporting research activity and is fuelling growth of this segment market.

Based on therapeutic area, the malignancies segment accounted for the largest share in the cell therapy market in 2020 and will continue to hold its market position throughout the forecast period.

On the basis of therapeutic area, the global cell therapy market can be segmented as malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and other therapies. The malignancies segment has accounted for the largest share in the cell therapy market in 2020 and will continue to hold its market position throughout the forecast period. Increasing obese population and majority of individuals suffering from malignant tumour are seeking for cell therapy. This is a key factor driving growth of the global market.

However, autoimmune disease segment is expected to register a notable growth owing to rising prevalence of various autoimmune disease such as rheumatoid arthritis across the globe.

Based on therapy type, the autologous segment has accounted for the largest share in the cell therapy market in 2020 and will continue to hold its market position throughout the forecast period.

On the basis of therapy type, the global cell therapy market can be segmented as autologous and allogeneic. The autologous therapy segment has accounted for the largest share in the cell therapy market in 2020 and will continue to hold its market position throughout the forecast period. This therapy is considered ideal cell therapy as it induces growth of own stem cells in the human body. This is considered as a key treatment option in the cancer treatment; hence this segment is expected to witness a high growth in the near future.

Many patients opt for this treatment post chemotherapy. This treatment helps to kill cancerous cells which are remained post chemotherapy. Hence, this is another factor driving growth of this segment market.

Based on region, North America is the fastest-growing market and is expected to register highest growth in the global cell therapy market during the forecast period.

On the basis of region, the global cell therapy market can be segmented as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The North America region currently dominates the global cell therapy market. This is owing to presence of necessary infrastructure, key companies, and skilled labours in countries in the region. Moreover, high funding availability for research activities is another factor supporting North America market.

However, Asia Pacific region is expected to register highest growth during the forecast period. According to the World Bank, in terms of population Asia Pacific region is dominating the global market. Also, as per the Population Reference Bureau, India, China, and other emerging APAC countries had a combined population exceeding 4 billion in 2020. Growing income level of individuals residing in this region and improving healthcare facilities are some other factors supporting regional market. China is expected to hold the largest share in this region followed by India.

The report also provides in-depth analysis of market dynamics such as drivers, restraints opportunities and challenges

Drivers

  • Rising Prevalence Of Cancer
  • Growing Investment for R&D Activities

Restraints

  • Lack of Skilled Professionals in Emerging Economies

Opportunities

  • Investment by Several Players for Research Activities
  • Supportive Government Initiatives

COVID-19 Impact on the Cell Therapy Market Analysis

The COVID-19 outbreak has made a positive impact on cell therapy market. Outbreak of COVID- 19 results in delay for the treatment of cancer so the cancer patients opting the chimeric antigen receptor T-cell (CAR-T) therapy or hematopoietic cell transplantation (HCT) which is the major driving factor for the growth of the cell therapy market during this pandemic. Additionally, government also supporting cell banks also during this pandemic as demand of cell therapy increasing among the cancer patients is another boosting factor for the growth of target market. Stem cells therapy also is under research to trat sever Covid-19. Hence, investment by market players to develop therapy for Covid-19 is expected to accelerate the market growth.    

The report also provides in-depth analysis of key market trends

Sr No Trends Impact
1 The cell therapy industry is witnessing a rising trend of strategic initiatives by key players such as collaborations for research and product development. Additionally, significant investment for R&D activity Positive
2 Rising number of stem cell banks and increasing government support for stem cell banking are some other trends witnessed in the global market. In many countries stem cell banking has recently started and is gaining a significant growth. Positive

The report also provides in-depth analysis of recent News Developments and Investments

  • September 2020, the Stemedica Cell Technologies has received US FDA investigational new drug approval for MSCs to use in the treatment of moderate or sever covid-19
  • August 2020, Abu Dhabi Stem Cells Center located in UAE and Pluristem based in Israel are collaborated to develop the cell therapy for the treatment of covid-19.

Cell Therapy Market Company Profiles and Competitive Intelligence

The key players operating in the Cell Therapy Market are:

  • Osiris Therapeutics, Inc.
  • NuVasive, Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • Kolon Tissue Gene, Inc.
  • Stemedica Cell Technologies, Inc.
  • Mesoblast Ltd.
  • Cells for cells
  • HolostemTerapieAvanzate S.r.l.
  • Medipost Co., Ltd.
  • Takeda Pharmaceutical Company
  • RTI Surgical
  • AlloSource
  • CORESTEM
  • Smith & Nephew
  • Regrow Biosciences
  • Stempeutics Research

The unique insights provided by this Cell Therapy Market report also includes the following:

  • In-depth value chain analysis
  • Opportunity mapping
  • Sector snapshot
  • Key Players Positioning Matrix
  • Regulatory scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market trends
  • Covid-19 impact analysis
  • Product comparison
  • Pre & Post COVID 19 impacts on Cell Therapy Market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

How big the global cell therapy market?

The global cell therapy market was valued at USD 7.7 billion in 2020.

What is the estimated market growth rate of cell therapy market?

The cell therapy market is estimated to grow at a compound annual growth rate (CAGR) of 14.2% during 2021-2027.

What region has the largest share in cell therapy market?

In the base year 2020, North America region accounted for the largest share in the cell therapy market.

Who are the key players in the cell therapy market?

A few key players in the cell therapy industry includes Osiris Therapeutics, Inc., NuVasive, Inc., JCR Pharmaceuticals Co. Ltd., Kolon Tissue Gene, Inc., Stemedica Cell Technologies, Inc., Mesoblast Ltd., Cells for cells, Holostem Terapie Avanzate S.r.l. among many others.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

Table of Contents Cell Therapy Market

  • INTRODUCTION
    • Product Outline
    • What is Cell Therapy
    • Different types of Cell Therapies
    • Analysis of Cell Therapy Ecosystem
    • Supply Chain Analysis
    • Covid -19 Impact
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
      • Threats
    • Technology Overview
    • Patent Analysis
  • Regulatory Landscape for Cell Therapy    
    • Regulations and Standards
  • Cell Therapy Products Market Pricing Analysis
    • Prices of Cell Therapy Products
  • Cell Therapy Market by Cell Type
    • Stem Cell
      • Bone Marrow
      • Blood & Umbilical Cord-Derived Stem Cells
      • Adipose-Derived Stem Cell
      • Others
    • Non-stem Cell
  • Cell Therapy Market by Therapeutic Area
    • Malignancies
    • Musculoskeletal Disorders
    • Autoimmune Disorders
    • Dermatology
    • Other Therapies
  • Cell Therapy Market by Therapy Type
    • Autologous
    • Allogeneic
  • Regional Analysis
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Norway
      • Italy
      • Spain
      • Netherlands
      • Rest Of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • New Zealand
      • Rest Of Asia Pacific
    • Middle East and Africa
    • South America
  • Key Strategic Insights
    • New Applications
    • Emerging Technologies
    • Opportunity mapping
    • Critical Success Factors
    • Consumer preferences
  • Key Market Trends / Recent Developments
  • Competitive Scenario
    • Competitive Strategies of Key Players
      • Mergers and Acquisitions
      • Investments
      • Joint Ventures
      • New Product launches
    • Ranking of Key Players
  • Key Global Players
    • Osiris Therapeutics, Inc.
    • NuVasive, Inc.
    • JCR Pharmaceuticals Co. Ltd.
    • Kolon Tissue Gene, Inc.
    • Stemedica Cell Technologies, Inc.
    • Mesoblast Ltd.
    • Cells for cells
    • Holostem Terapie Avanzate S.r.l.
    • Medipost Co., Ltd.
    • Takeda Pharmaceutical Company
    • RTI Surgical
    • AlloSource
    • CORESTEM
    • Smith & Nephew
    • Regrow Biosciences
    • Stempeutics Research

Choose License
Buy Now
Why Choose AllTheResearch?
  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on “Quadrant Positioning” of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports. Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.


Quick Inquiry
Follow Us
Choose License
Buy Now